MB-105 in Patients With CD5 Positive T-cell Lymphoma
NCT06534060
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
46
Enrollment
INDUSTRY
Sponsor class
Conditions
Lymphoma, T-Cell
Interventions
BIOLOGICAL:
Genetic: MB-105
Sponsor
March Biosciences Inc